Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
Clinical trial NCT00847899 · COMPLETED
Trial details
- NCT number
- NCT00847899
- Sponsor
- Arete Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.